ALCOR — Biocorp Production SA Balance Sheet
0.000.00%
HealthcareSpeculativeSmall Cap
- €154.39m
- €157.50m
- €11.67m
Annual balance sheet for Biocorp Production SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.34 | 2.01 | 4.98 | 1.85 | 2.67 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.59 | 1.19 | 1.36 | 2.69 | 3.98 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.44 | 4.77 | 7.78 | 6.49 | 8.73 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.25 | 1.51 | 3.3 | 3.55 | 3.38 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5.08 | 6.77 | 11.7 | 10.7 | 12.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.34 | 3.04 | 5.74 | 4.14 | 5.35 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.9 | 6.74 | 8.87 | 7.53 | 10.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -1.82 | 0.032 | 2.84 | 3.12 | 2.46 |
| Total Liabilities & Shareholders' Equity | 5.08 | 6.77 | 11.7 | 10.7 | 12.6 |
| Total Common Shares Outstanding |